Darling Ingredients heads into its July 30 earnings report with analysts turning more optimistic — yet short sellers have quietly grown more aggressive over the same period.
The most striking move on the analyst desk came this morning: TD Cowen lifted its price target from $70 to $80, maintaining Buy, just days before the print. That reverses the same firm's cut in late June. JP Morgan's Overweight and Jefferies' Buy also carry targets in the $75–$79 range. The consensus mean target is $76.25, implying roughly 26% upside from the current price of $60.53. Barclays is the dissenting voice, raising its target only to $62 — essentially flat to where the stock trades now — and sticking with Equal-Weight. The bull camp is betting on continued strength in sustainable ingredients and biofuel feedstock demand. Bears, led by Barclays' more cautious stance, appear focused on valuation and the narrowing margin between current price and the Street's aggregate target, which has closed sharply as the stock rallied over 15% in the past month.
Short interest, however, tells a more cautious story than the analyst optimism suggests. Bears have added exposure steadily: short positions have climbed 15% over the past month and 4% in the past week, reaching 5.3% of the free float. That is a meaningful and accelerating build. Yet the borrow market offers little sign of a squeeze dynamic — availability is enormous at around 3,097% of outstanding short interest, meaning shares are in abundant supply for anyone who wants to add to a short position. Cost to borrow is also low at 0.45%. The borrow market is loose, not tight, so the growing short base reflects genuine conviction rather than any forced technical positioning.
Options positioning offers little drama ahead of the print. The put/call ratio is essentially flat to its 20-day average at 0.39, with a z-score near zero. There is no outsized demand for downside protection — options traders have not taken a strong directional stance. The stock's recent history of earnings reactions has been tame: the last three prints produced day-one moves well under 2% on average, with a slight drift lower over the subsequent five trading days. Peers ADM and BG both fell around 3% on Monday and are down roughly 2.5–3.5% on the week, suggesting the broader agricultural processing complex faces some headwinds that DAR has not yet fully absorbed.
EPS momentum is genuinely exceptional heading into the report — the 90-day forward EPS estimate revision ranks in the 97th percentile of the ORTEX universe — making the July 30 print a direct test of whether Darling can validate that earnings trajectory at a margin level that justifies both the stock's 15% monthly run and the analysts' freshly-raised targets.
See the live data behind this article on ORTEX.
Open DAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
